Horst Beckmann

1.5k total citations · 1 hit paper
5 papers, 1.1k citations indexed

About

Horst Beckmann is a scholar working on Hematology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Horst Beckmann has authored 5 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 1 paper in Infectious Diseases and 1 paper in Molecular Biology. Recurrent topics in Horst Beckmann's work include Hemophilia Treatment and Research (3 papers), Platelet Disorders and Treatments (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Horst Beckmann is often cited by papers focused on Hemophilia Treatment and Research (3 papers), Platelet Disorders and Treatments (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Horst Beckmann collaborates with scholars based in Germany, United States and Sweden. Horst Beckmann's co-authors include Sylvia Haas, Frank Misselwitz, Lars C. Borris, Richard J. Friedman, Menno V. Huisman, Ajay K. Kakkar, William Geerts, Bengt I. Eriksson, Eva Muehlhofer and Tiemo J. Bandel and has published in prestigious journals such as New England Journal of Medicine, Thrombosis Research and Vox Sanguinis.

In The Last Decade

Horst Beckmann

5 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

2008 1.0k citations Bengt I. Eriksson, Lars C. Borris et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Horst Beckmann Germany	4	940	872	232	122	85	5	1.1k
William D. Fisher Canada	8	987 1.1×	1.0k 1.2×	229 1.0×	137 1.1×	76 0.9×	12	1.2k
A. Planès France	10	653 0.7×	496 0.6×	335 1.4×	75 0.6×	88 1.0×	23	760
N Vochelle France	12	1.1k 1.1×	829 1.0×	508 2.2×	95 0.8×	143 1.7×	20	1.2k
Marjolein Brekelmans Netherlands	14	476 0.5×	368 0.4×	165 0.7×	108 0.9×	44 0.5×	19	628
Jan Beyer‐Westendorf Germany	15	1.2k 1.3×	1.2k 1.3×	297 1.3×	224 1.8×	50 0.6×	28	1.4k
Gloria Kayani United Kingdom	22	636 0.7×	1.3k 1.5×	150 0.6×	84 0.7×	44 0.5×	45	1.5k
N. Ruiz‐Giménez Spain	11	748 0.8×	615 0.7×	194 0.8×	113 0.9×	31 0.4×	19	845
Alexander GG Turpie Canada	9	1.5k 1.6×	1.3k 1.5×	510 2.2×	203 1.7×	164 1.9×	17	1.7k
Lynn B. Oertel United States	8	312 0.3×	980 1.1×	130 0.6×	52 0.4×	49 0.6×	11	1.1k
J.J.C. Jonker Netherlands	12	309 0.3×	473 0.5×	156 0.7×	56 0.5×	50 0.6×	22	666

Countries citing papers authored by Horst Beckmann

Since Specialization

Citations

This map shows the geographic impact of Horst Beckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horst Beckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horst Beckmann more than expected).

Fields of papers citing papers by Horst Beckmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Horst Beckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horst Beckmann. The network helps show where Horst Beckmann may publish in the future.

Co-authorship network of co-authors of Horst Beckmann

This figure shows the co-authorship network connecting the top 25 collaborators of Horst Beckmann. A scholar is included among the top collaborators of Horst Beckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Horst Beckmann. Horst Beckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kenet, Gili, Rolf Ljung, L. Rusen, et al.. (2020). Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study. Thrombosis Research. 189. 96–101. 3 indexed citations

2.

Mahlangu, Johnny, et al.. (2020). BAY 81‐8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years. European Journal Of Haematology. 104(6). 594–601. 1 indexed citations

3.

Zhao, Yongqiang, Juan Xiao, Renchi Yang, et al.. (2017). Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A. Pediatric Hematology and Oncology. 34(3). 146–156. 15 indexed citations

4.

Eriksson, Bengt I., Lars C. Borris, Richard J. Friedman, et al.. (2008). Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty. New England Journal of Medicine. 358(26). 2765–2775. 1047 indexed citations breakdown →

5.

Wehmeier, A., Anna Maria Eis‐Hübinger, Monika Maas Enriquez, & Horst Beckmann. (2000). Parvovirus B19 in Idiopathic Thrombocytopenic Purpura. Vox Sanguinis. 79(2). 118–118. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact